Arrow image

23 Jan 2024

Going from Bench to PDF with Strand's PQRS software

WRITTEN BY

Divya Anantsri

SHARE THIS

Blog

Quantitative polymerase chain reaction (qPCR) is a well-established technique for high-throughput quantification of target DNA sequences. In infectious disease testing, qPCR is indispensable for rapid and accurate pathogen identification. Despite its widespread use and relevance for clinical decisions, automated solutions in the qPCR workflow are limited, causing delays and increased labor for laboratory scientists.

Strand's software team has recently developed an end-to-end qPCR software solution (PQRS) for infectious disease reporting.

Sample to PDF report workflow

The process is initiated by the input of qPCR output files, which could be antibiotic susceptibility testing (AST) files, raw result files, or any other input data file. 

Next, a report based on a configurable template is compiled and generated. The platform leverages a curated knowledge base drawing from several key reference databases.

Reference databases used to develop our curated knowledge base

A quick review by a Senior Scientist follows, and the report is made available as a PDF download. It is worth highlighting that the turnaround time from input to report generation is just under a minute 

To learn more about how the PQRS platform facilitates infectious disease reporting specifically, urinary tract infection (UTI) reporting, join us for an insightful discussion with Dr. Federica Gibellini and learn how AccessDx Lab's UTI panel and Strand's PQRS portal work together to enhance point-of-care UTI testing. 

Catch the talk at PMWC - Precision Medicine World Conference in Silicon Valley, California, on Wednesday, January 24th, at 3:30 PM PST!

Today’s Pick
from Blogs

11 Sep 2025

Accelerating Single-Cell Metadata Normalization and Harmonization through Strand's RAG+LLM Pipeline

Badri Padhukasahasram, Shrutee Jakhanwal and Chinta Sidharthan

Know More

30 Jun 2025

Strand’s Bioinformatics Expertise Enables Liquid Biopsy Assay Development for NSCLC with 70% Cost Reduction and 2–5% VAF Sensitivity

Suhasini Singh

Know More

Your Next
Blog Recommendations

09 Jan 2025

AI/ML Series

1 | Standardized Data Harmonization Workflows

Sakshi Shinghal

Know More

12 Aug 2024

FDA Rule on Lab Developed Tests (LDTs)

1 | FDA Final Rule Affects Regulatory Oversight of LDT Manufacturers

Divya Anantsri

Know More

21 Oct 2024

Microbiome Analysis Series

1 | An Ecosystem of Possibilities—Applications of Microbiome Analysis

Sanjna Banerjee

Know More

Let's
Talk

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Form
About image
Please fill out this form to
download the case study.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.